Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Evaluation of the Impact of Residual Astigmatism on the Visual Performance With Clareon Vivity

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

This single visit study is designed to help understand how vision is affected if the eye still has astigmatism after cataract surgery. Participants will be individuals who have already undergone cataract surgery and received a Clareon Vivity IOL in both eyes at least 4 months prior to study enrollment. During the study visit, trial lenses (glass lenses that are used during an eye exam) will be used to temporarily create the effect of astigmatism on the eye.

Inclusion Criteria:

• Able to understand and sign an Institution Review Board-approved informed consent form;
• Willing and able to attend all scheduled study visits as required by the protocol;
• Implanted with study IOLs in both eyes at least 4 months prior to study participation;
• Best Corrected Distance Visual Acuity (BCDVA) of 0 logarithm minimum angle of resolution (logMAR) or better in each eye.

Exclusion Criteria:

• Residual astigmatism greater than or equal to 1.00 diopter (D);
• Clinically significant ocular conditions as specified in the protocol;
• History of ocular surgeries other than limbal relaxing incisions
• Other protocol-specified exclusion criteria may apply.